comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-27 10:26:57 - browse：5

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Scientists unlock the key to scar

knowledge

WSS

2023 STAT Wunderkinds: get to know the winners

CEOs share strategies for surviving biotech slump

Covid isolation guidance eased by the CDC

2023 STAT Wunderkinds: get to know the winners

ALS groups 'won't be played again' by the FDA, drug sponsors

FDA warns J&J's Abiomed: We will regulate your software

explore

comprehensive

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

International team creates first chimeric human

Novavax promises a turnaround & Lilly roils the obesity market

STAT Readout Newsletter: Today's biggest biotech updates

Hollywood unions extend contract negotiations for actors

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Dobbs anniversary: the lost opportunity of abortion as health care

First Opinion Podcast: Long Covid needs a new approach

After affirmative action ruling, medical educators look to 'holistic review'

Obesity now affects over 1 billion people worldwide, study finds

focus

The EU Joint Clinical Assessment needs to live up to its promise

STAT Summit: GSK CEO on pharma giant's new direction

FDA does about

The EU Joint Clinical Assessment needs to live up to its promise

Beam Therapeutics to lay off 20% of its staff, re

House looks to weaken Medicare negotiation

knowledge

knowledge

Wikipedia

hotspot